Warner Bros. Discovery, Inc.
Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof
Last updated:
Abstract:
A novel five-membered heteroaromatic imidazole compound and use thereof is disclosed herein. Specifically, disclosed is a compound as shown in formula (III) or a pharmaceutically acceptable salt thereof. Also disclosed is a method for treating a disease related to GLP-1 receptor such as type II diabetes. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
13 Jan 2022
Issue date:
5 May 2022